(B) | 1. |
¤U¦C¦³Ãö¶Ý¥ì¬õG¸zª¢¡]eosinophilic gastroenteritis¡^¤§±Ôz¡A¦óªÌ¦³»~¡H
|
A. | ¥iµo¥Í©óG¡B¤p¸z©Îµ²¸z¡C |
B. | ¶Ý¥ì¬õ²y®û¼í¦bÖß½¤¼h¡C |
C. | ¸¡µh¡B¸¡Âm¡B¹½¹¡Bäú¤ßµ¥¬O±`¨£¯gª¬¡C |
D. | ±`¦³¶gÃä¦å²G¤¤¶Ý¥ì¬õ²y¼W¥[¡C |
E. | ¦h¼Æ¯f±w»Ý¥Î¥Ö½èÃþ©T¾JªvÀø¡C |
|
(B) | 2. |
¦³Ãö¦UºØÀç¾i¦b¸z¹D§l¦¬¤§³¡¦ì¡A³J¥Õ½è¥Dn§l¦¬¬O¦b
|
A. | ¤p¸zªñºÝ |
B. | ¤p¸z¤¤ºÝ |
C. | ¤p¸z»·ºÝ¡]°j¸z¡^ |
D. | ¤p¸z»·ºÝ¤Îª¼¸z |
E. | ¤p¸z»·ºÝ¤Îµ²¸z |
|
(B) | 3. |
¦³Ãö¯ØŦ°²©ÊÅn¸~¡]pseudocyst¡^¤§±Ôz¡A¦óªÌ¬°»~¡H
|
A. | ¤j³¡¥÷¬O¥Ñ¯ØŦª¢¡A¤Ö³¡¥÷¥Ñ¥~¶Ë³y¦¨¡C |
B. | ¤j¦h¼Æ¦ì©ó¯ØŦÀY³¡¤ÎÅ鳡¡C |
C. | Ån¸~¾À¤WµL¤W¥Ö²ÓM¦s¦b¡C |
D. | ¦h¼Æ±wªÌ¦å²M¾ý¯»úC¼W°ª¡C |
E. | °²©ÊÅn¸~¥i¯à§Î¦¨ÁwºÅ¡C |
|
(D) | 4. |
¯×ªÕ¨x¥i¤À¬°¤j©Î¤p¯×ªÕªw¡]fat droplet¡^¦b¨x²ÓM¤º¡A¦ÓºÙ¬° macrovesicular ¤Îmicrovesicular fatty liver¡C¤U¦C¤Þ°_¯×ªÕ¨xªºì¦]¤¤¡A¦óªÌ«Y¾ÉP microvesicular fatty liver¡H
|
A. | °sºë©Ê¨x¯f |
B. | ªÎD¯g |
C. | Àç¾i¤£¨} |
D. | Ãh¥¥«æ©Ê¯×ªÕ¨x¡]acute fatty liver of pregnancy¡^ |
E. | ¥þÀR¯ßÀç¾i¡]total parenteral nutrition¡^ |
|
(A) | 5. |
¦³Ãö¼ìºÅ©Êµ²¸zª¢°ü¤k±wªÌÃh¥¥¤§±Ôz¡A¦óªÌ¬°»~¡H
|
A. | ¸û¤@¯ë¤H©ö¦³¦º²£¡]stillbirth¡^¡B¦²£¤§¥i¯à¡C |
B. | ¦bÃh¥¥²Ä¤@¤TÓ¤ë´Á¡]first trimester¡^¤Î²£«á´Áª¢¯g©ö´_µo¡C |
C. | Sulfasalazine ¤§¨Ï¥Î¦üµL®`¥çµL·î§Îµo¥Í¡C |
D. | Corticosteroids ¥i¨Ì¥±`¶q¨Ï¥Î¡C |
E. | §K¬Ì§í¨î¾¯¡]immunosuppressive agent¡^¶·ÁקK¨Ï¥Î¡C |
|
(D) | 6. |
¤U¦C¦UºØ±¡§Î¤¤¡A¦óªÌ¸û¤£¥i¯à²£¥Í¤p¸z¤º²Óµß¹L«×¥Íªø¡]intestinal bacterial overgrowth¡^¡H
|
A. | ©ñ®g½u¸zª¢¡]Radiation enteritis¡^ |
B. | ¿}§¿¯f |
C. | µw¥Ö¯f¡]Scleroderma¡^ |
D. | G»Ä¹L°ª¡]Hyperacidity¡^ |
E. | ªø´Á¨Ï¥Î²Õ´«ú§Ü¾¯¡]H2 receptor antagonist¡^ |
|
(E) | 7. |
¤U¦C¦UºØ¸¡Âm¤¤¡A¦óªÌ¤£ÄÝ©ó¤Àªc©Ê¸¡Âm¡]Secretory diarrhea¡^¡H
|
A. | ²Óµß©Êµg¯e |
B. | ¤fª¢©Ê¸¡Âm¡]Celiac sprue¡^ |
C. | ÃþÀù¯gÔ¸s¡]Carcinoid syndrome¡^ |
D. | ¼ìºÅ©Êµ²¸zª¢¡]Ulcerative colitis¡^ |
E. | «æÀê©Ê¸z¯gÔ¸s¡]Irritable bowel syndrome¡^ |
|
(A) | 8. |
¹¹D¹B°Ê§ÎºA¡]motility pattern¡^Åã¥Ü¤¤¤UºÝ¦¬ÁY®¶´T¡]amplitude of contraction¡^´î¤Ö¡A¥B¤U¹¹DÂX¬ù¦Ù³B©ó§CÀ£¡]hypotension¡^¡A¨ä¥i¯à¤§¶EÂ_¬°
|
A. | µw¥Ö¯f¡]Scleroderma¡^ |
B. | ¹¹D¥¢¦¢½w¯g¡]Achalasia¡^ |
C. | ¹¹DµjÅË¡]Spasm¡^ |
D. | ¦hµo©Ê¦Ùª¢¡]Polymyositis¡^ |
E. | ¹¹Dµõ¤Õª·®ð¡]Hiatal hernia¡^ |
|
(C) | 9. |
¤U¦CÃĪ«¤¤¡A¦óªÌ¥i¾ÉPÁx¥Äº¢¯d¡]cholestasis¡^
(1) Halothane
(2) Methyltestosterone
(3) Acetaminophen
(4) Erythromycin
(5) Cyclosporine
|
A. | 1,2,4 |
B. | 2,3,4 |
C. | 2,4,5 |
D. | 1,2,3 |
E. | 2,3,4 |
|
(C) | 10. |
¤U¦C±¡ªp¡A¦óªÌ¤£³Q¦Ò¼{¬°Áx©T¾Jµ²¥Û¤§¦¨¦]¡G
(1) ªø´ÁÀR¯ßÀç¾i
(2) ºC©Ê·»¦å¯e¯f¡]Chronic hemolysis¡^
(3) °j¸z¯e¯f©Î¤Á°£¡]Ileal disease or resection¡^
(4) °§¾j¡BÅé«´î»´
(5) ºC©ÊÁx¹D·P¬V¡]Chronic biliary infection¡^
|
A. | 1,2 |
B. | 2,3 |
C. | 2,4 |
D. | 2,5 |
E. | 3,4,5 |
|
(C) | 11. |
¤U¦C¯ØŦ¸~½F¤¤¡A¦óªÌ¥i¾ÉP¦å¿}¹L°ª¯g¡H
(1) G¿E¯À½F¡]Gastrinoma¡^
(2) ¯Ø®q¯À½F¡]Insulinoma¡^
(3) ¦å¿}¿E¯À½F¡]Glucagonoma¡^
(4) ¥Íªø§í¨î¯À½F¡]Somatostatinoma¡^
(5) ÃþÀù¡]Carcinoid¡^
|
A. | 1,2 |
B. | 2,3 |
C. | 3,4 |
D. | 4,5 |
E. | 3,5 |
|
(B) | 12. |
Ãö©ó¨x¯f¤§¶EÂ_¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H
|
A. | ¨xª¢¤§¶EÂ_¥Dn¨Ì¿à¦å²M GOT¡]AST¡^¤Î GPT¡]ALT¡^¤§¼ÆÈ¡C |
B. | ¨xµw¤Æ¤§¶EÂ_¥Dn¨Ì¿à¦å²Malkaline phosphatase¡]ALP¡^¤Î£^-GT¡C |
C. | ¨x²ÓMÀù¤§¶EÂ_¥Dn¨Ì¿à¸¡³¡¶Wµªi±½´y¤Î¦å²ML¨à³J¥Õ¼ÆÈ¡C |
D. | ¨xÁwºÅ¤§¶EÂ_¥Dn¨Ì¿à¯f±w¤§¯gª¬¤Î¸¡³¡¶Wµªi±½´y¡C |
E. | Âಾ©Ê¨xÀù¤§¶EÂ_¥Dn¨Ì¿à¶Wµªi«ü¤Þ¤U¤§¨x¬ï¨ë¡A¨Ã°e¯f²z¬ìÀˬd¡C |
|
(E) | 13. |
¤@¦ì«æ©Ê¨xª¢±wªÌ¡A©â¦åÀËÅçµ²ªG¦p¤U¡GGOT(AST)=1200(<31)¡AGPT(ALT)=1000(<31)¡AHBsAg(+)¡Aanti-HBs(-)¡AIgM anti-HBc(-)¡AIgM anti-HAV(+)¡Aanti-HCV(-)¡Aanti-HDV(-)¡A½Ð°Ý¨ä¶EÂ_¬°¤U¦C¦óªÌ¡H
|
A. | «æ©ÊB«¬¨xª¢ |
B. | «æ©ÊA«¬¨xª¢¥[¤W«æ©ÊB«¬¨xª¢ |
C. | «æ©ÊC«¬¨xª¢¥[¤W«æ©ÊB«¬¨xª¢ |
D. | «æ©ÊB«¬¨xª¢¥[¤W«æ©ÊD«¬¨xª¢ |
E. | «æ©ÊA«¬¨xª¢µo¥Í©óB«¬¨xª¢±aìªÌ |
|
(E) | 14. |
¤@¦ì¯f¤H¦í°|«á¡A©â¦åÀËÅç©Ò±oµ²ªG¦p¤U¡GGOT(AST)=80(<31)¡AGPT(ALT)=77(<31)¡Aalkaline phosphatase (ALP)=450(<238)¡A£^-GT=240(<50)¡Abilirubin(T/D)=1.0/0.4¡A½Ð°ÝÀ³¦A¦w±Æ¤U¦C¨º¨ÇÀˬd¡H°£¤F¡G
|
A. | ¸¡³¡¶Wµªi±½´y¡]Abdominal ultrasound¡^ |
B. | ¸¡³¡¹q¸£Â_¼hÄá¼v¡]Abdominal computed tomography¡^ |
C. | ¨x¬ï¨ëÀˬd¡]Liver biopsy¡^ |
D. | ¦å²Mantimitochondrial antibodyÀËÅç |
E. | ¨xŦRBC scan |
|
(D) | 15. |
¤@¦ì¯f¤H¦] intermittent leg edema ¤Î¨{¤l¤W¦³ superficial vein engorgement ¦Ó¦í°|Àˬd¡C¨ä¨{¤l¤W¤§ superficial veins ¤À§G¦b¨â°¼¡A¦å¬y¤è¦V©¹¤W¡C±z¥i¯à¬°¯f¤H¦w±Æ¤U¦CÀˬd¡A°£¤F¡G
|
A. | Venography of inferior vena cava ( IVC ) with measurements of pressure of IVC and hepatic vein, if possible |
B. | Abdominal ultrasound |
C. | Magnetic resonance image |
D. | Liver radionuclide scan |
E. | Cardiac catheterization with measurements of pressure of IVC and hepatic vein, if possible |
|
(D) | 16. |
¦³¦ì¯f¤H¨Ó°|´NÂå¡A¥D¶D¥k¤W¸¡µh¡A¥Bµo°ª¿N¤Î´HŸ¡C²z¾ÇÀˬdµo²{±wªÌ¤§¥k¤W¸¡¦³Ä²µh¡]tenderness¡^¡C¦å²GÀˬdÅã¥Ü¥Õ¦å²y¼Æ¥Ø¬°15,000¡A¨ä¤¤85%¬°¦h§Î®Ö¥Õ¦å²y¡]polymorphonuclear cells¡^¡C½Ð°Ý¤U¦C¦U¶µ±Ôz¦óªÌ¿ù»~¡H
|
A. | ¨ä¶EÂ_¥i¯à¬°«æ©ÊÁxÅnª¢¡C |
B. | ¨ä¶EÂ_¥i¯à¬°«æ©ÊÁxºÞª¢¡C |
C. | ¨ä¶EÂ_¥i¯à¬°¨xÁwºÅ¡C |
D. | Y²z¾ÇÀˬd¦³Murphy's sign¡A¤~µý¹ê¨ä¬°¨xÁwºÅ¡C |
E. | À³°¨¤W¦w±Æ¸¡³¡¶WµªiÀˬd¡C |
|
(A) | 17. |
¤U¦CÃö©ó¨xµw¤Æ¤§±Ôz¡A¦óªÌ¿ù»~¡H
|
A. | ¯f¤H¨{ÂÀ¨â°¼¥~¥i¯à¥X²{ª½¦æ¦å¬y ¦V¤W¡]ÀY³¡¡^¤§ superficial veins¡A¿×¤§caput medusae¡C |
B. | ¯f¤H¨¤W¥i¯à¥X²{ spider naevi ¤Î palmar erythema µ¥ªí¼x¡]sign¡^¡C |
C. | ¸¡³¡¶Wµªi±½´y¥i¥Î¬°¿zÀ˨xµw¤Æ¤§¤u¨ã¡C |
D. | ¸¡µÄÃè¥[¤W¨x¬ï¨ë¬°³Ì½T¹êªº¶EÂ_¤èªk¡C |
E. | Y¦] portal hypertension ¦Ó¥X²{¸¡¤ô¡A¥i¨Ï¥Î spironolactone ªvÀø¤§¡C |
|
(D) | 18. |
¤@¦ì¯f¤H¦]¸¡³¡³vº¥µÈ¤j¦Ó¨DÂå¡A¤U¦C±Ôz¦óªÌ¿ù»~¡H
|
A. | Y²z¾ÇÀˬd¥X²{ shifting dullness¡Aªí¥Ü¦³¸¡¤ô¡AÀ³¥ß§Y©â¨ú¸¡¤ôÀËÅç¡C |
B. | Y serum albumin level ´î¥h ascites albumin level ¤§È¤p©ó1.1gm%¡Aªí¥Ü¬°exudate¡C |
C. | Y¬° exudate ascites¡A¥B¨ä¤¤ WBC=550¡]neutrophil=300¡^¡Aªí¥Ü¦³ bacterial peritonitis¡C |
D. | Y¸¡¤ô¤¤ WBC=1000¡]neutrophil=600¡^¡A¦ý¨ä bacterial culture ¬°³±©Ê¡Aªí¥Ü¤£¥i¯à¬° bacterial peritonitis¡C |
E. | Y¬° exudate ascites¡A¥B WBC=100¡A«hÀ³¦w±Æ¸¡µÄÃèÀˬd¡C |
|
(B) | 19. |
¤U¦CÃö©ó¨x²ÓMÀù¤§±Ôz¡A¦óªÌ¿ù»~¡H
|
A. | 3¤½¤À¥H¤U¤§¤p«¬¨x²ÓMÀù¡A¦å²M¥ÒºØL¨à³J¥Õ¡]£\-fetoprotein¡^¼ÆÈ¥i¯à¥¿±`¡C |
B. | ¦b¦³¸gÅ窺Âå®v¤â¤¤¡A¬én¤j©ó1¤½¤À¤§¨x²ÓMÀù¡A¤@©w¯à¥H¶Wµªi»ö±½´y¥X¨Ó¡C |
C. | ¨x²ÓMÀù±wªÌ¡A³q±`¥ç¿©±w¨xµw¤Æ¡C |
D. | ¤p«¬¨x²ÓMÀù¤§ªvÀø¤èªk¥]¬A¶}¤M¡B¨x°Ê¯ß¦åºÞ®ê¶ë¡B°sºëª`®g¡C |
E. | ¨x²ÓMÀù±`¨£ªºÂಾ¦ì¸m¬°ªÍ³¡¤Î°©ÀY¡C |
|
(B) | 20. |
¤@¦ìB«¬¨xª¢±aìªÌ¦]¬¡°Ê©ÊªÍµ²®Ö¦Ó±µ¨ü¤U¦CÃĪ«ªvÀø¡Gisoniazid , ethambutol , rifampicin ¤Î streptomycin¡C¤@Ó¤ë«á©â¦åÀËÅçµo²{ GPT=700(<31)¡AGOT=800(<31)¡A¨x¥\¯à¤§¨ä¥L¶µ¥Ø¤´¦b¥¿±`½d³ò¤º¡C¤U¦C¦U¶µ±Ôz¡A¦óªÌ¿ù»~¡H
|
A. | ¯f¤H¥i¯àµo¥ÍÃĪ«©Ê¨xª¢¡A¬GÀ³¥ß§Y°±¤îµ²®Ö¤§ªvÀø¡C |
B. | Y°±ÃĤG¶g«á¡A¨ä¦å¤¤ GPT=650¡AGOT=550¡A«h¤ä«ùÃĪ«©Ê¨xª¢¤§¶EÂ_¡C |
C. | ¯f¤H¥i¯àµo¥ÍºC©ÊB«¬¨xª¢¤§«æ©Êµo§@¡C |
D. | ¹ï¦¹¯f¤HÀ³©â¦åÀËÅç anti-HCV ¤Î anti-HDV¡A¥H±Æ°£superinfection ¤§¥i¯à¡C |
E. | ¯f¤H©â¦åÀËÅç IgM anti-HAV §e³±©Ê¤ÏÀ³¡Aªí¥Ü¨Ã«D«æ©Ê A «¬¨xª¢¡C |
|
(D) | 21. |
¦³¦ì¯f¤H´NÂå®É¥D¶D¦³ tea-colored urine¡A¨ä sclera µy·L icteric¡A©â¦åÀËÅç½T¹ê¦³ hyperbilirubinemia¡A½Ð°Ý¸Ó¯f¤H¤£¥i¯à¬°¤U¦C¦óºØ¯e¯f¡H
(1) Hemolysis
(2) Cholestasis
(3) Dubin-Johnson syndrome
(4) Gilbert's syndrome
(5) Obstructive jaundice
|
A. | 1,2 |
B. | 1,2,4 |
C. | 3,4,5 |
D. | 1,4 |
E. | 2,3,5 |
|
(C) | 22. |
¤U¦CÃö©ó¨xª¢¯f¬r¤§±Ôz¡A¦óªÌ¿ù»~¡H
(1) HCV¬°DNA¯f¬r¡A¨ä¼ç¥ñ´Á¬ù2¶g
(2) HBV¬°DNA¯f¬r¡A¨ä¶Ç¼½¥Dn¬°¶¼¹¶Ç¬V
(3) HAV¬°RNA¯f¬r¡A¨ä¶Ç¼½¥Dn¬°©Ê¥æ¶Ç¬V
(4) HDV¬°RNA¯f¬r¡A¨ä¶Ç¼½¥Dn¬°©Ê¥æ¶Ç¬V
(5) HEV¬°RNA¯f¬r¡A¨ä¶Ç¼½¥Dn¬°¶¼¹¶Ç¬V
|
A. | 1,2,3,4,5 |
B. | 1,2,3,4 |
C. | 1,2,3 |
D. | 1,2 |
E. | 1 |
|